The potential for HIF-1α to become a prognostic marker was further strengthened by a meta-analysis on bone tumors that revealed a significant correlation between the overexpression of HIF-1α and overall/disease-free survival [99]. This evidence concerns the gene HIF1A and bone neoplasm.